These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 1982063)

  • 1. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer.
    Schwab M; Amler LC
    Genes Chromosomes Cancer; 1990 Jan; 1(3):181-93. PubMed ID: 1982063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene amplification in neoplastic development and progression of human cancers.
    Schwab M
    Crit Rev Oncog; 1990; 2(1):35-51. PubMed ID: 2091749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene amplification in tumor cells.
    Alitalo K; Schwab M
    Adv Cancer Res; 1986; 47():235-81. PubMed ID: 3022564
    [No Abstract]   [Full Text] [Related]  

  • 4. Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance.
    Gutman M; Ravia Y; Assaf D; Yamamoto T; Rozin R; Shiloh Y
    Int J Cancer; 1989 Nov; 44(5):802-5. PubMed ID: 2573579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amplification of N-myc in neuroblastoma: paradigm for clinical use of an oncogene alteration].
    Schwab M
    Klin Padiatr; 1990; 202(4):197-201. PubMed ID: 2203936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where pathology meets molecular biology: N-myc amplification in human neuroblastoma as a paradigm for the clinical use of an oncogene alteration.
    Schwab M
    Verh Dtsch Ges Pathol; 1994; 78():26-33. PubMed ID: 7533996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetics and DNA amplification in colorectal cancers.
    Brüderlein S; van der Bosch K; Schlag P; Schwab M
    Genes Chromosomes Cancer; 1990 May; 2(1):63-70. PubMed ID: 1980607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.
    Knyazev PG; Imyanitov EN; Chernitca OI; Nikiforova IF; Hanson KP
    Oncology; 1992; 49(2):162-5. PubMed ID: 1349430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
    Ibson JM; Rabbitts PH
    Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
    Bergh JC
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
    Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes in clinical cancer--a panel discussion.
    McGuire WL; Johnson BE; Seeger RC; Slamon DJ
    Breast Cancer Res Treat; 1987 Dec; 10(3):217-27. PubMed ID: 2833962
    [No Abstract]   [Full Text] [Related]  

  • 13. [Amplification of the erbb-2 (Her-2/NEU), erbb-1 (HER-1) and c-myc oncogenes is often combined with the deletion of the short arm of chromosome 17 in human carcinoma].
    Imianitov EN; Chernitsa OI; Nikiforova IF; Serova OM; Sokolov SI; Laur OIu; Togo AV; Kniazev PG
    Mol Biol (Mosk); 1993; 27(4):888-94. PubMed ID: 8103188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
    Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
    Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in copy number of c-erbB-2 and c-myc proto-oncogenes in advanced stage of human breast cancer.
    Tsuda H; Hirohashi S; Hirota T; Shimosato Y
    Acta Pathol Jpn; 1991 Jan; 41(1):19-23. PubMed ID: 1674395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
    Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
    J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
    Bellacosa A; de Feo D; Godwin AK; Bell DW; Cheng JQ; Altomare DA; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa JR
    Int J Cancer; 1995 Aug; 64(4):280-5. PubMed ID: 7657393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human small-cell lung cancers show amplification and expression of the N-myc gene.
    Nau MM; Brooks BJ; Carney DN; Gazdar AF; Battey JF; Sausville EA; Minna JD
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1092-6. PubMed ID: 2869482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.